Self-Amplifying RNA: Redefining RNA-Based Therapeutics
The global RNA therapeutics market is slated to reach $940-$950 million by 2035. Out of several promising advancements driving this growth, self-amplifying RNA therapeutics are currently leading the pack. saRNA vaccines offer protective immunity at doses that are 1,000,000-fold lower than their mRNA counterparts, with optimized platforms in preclinical models. Market leaders and leading researchers anticipate that this technology will dominate the next-generation RNA therapeutics, specifically in pulmonary and oncology treatments.
Does it get any better?
All these benefits are contradicted by a few structural and functional challenges that demand strategic solutions for the upscaling of production and adoption of saRNA technology. The large size of the molecule, target cell delivery inefficiencies, better capping technologies, and purification methods are some of the loopholes that need closing for its seamless commercialization.
Also, its high immunogenicity is a double-edged sword that needs to be tamed because overactivation of innate immunity could lead to RNA expression inhibition and several other adverse effects.
With market leaders like Pfizer, Arcturus, and Alnylam focusing their attention on addressing these challenges, the saRNA landscape is set to grow to its full potential by the end of this decade.
Stellarix Perspective
Net-zero hospitals have turned from an innovative ecological concept into an essential one. However, their seamless integration in healthcare can only be warranted with the seamless inclusion of digitally smart technologies. The deployment of IoT, AI/ML, and remote monitoring systems could be the key to mitigating the carbon footprint and providing better patient care. There is a whole story behind how these tech advancements are propagating growth and sustainable infrastructure development in healthcare.
Read end-to-end details at: Net-Zero Hospital: Role of DigiTech in Sustainable Healthcare
Our Latest Publications:
Green Hydrogen: Though green hydrogen investments are the talk of the town, there exists a substantial gap between ambition and implementation. These rising tides come with costs and investment risks, threatening the 2030 1.5 ℃ ambition.
Magnetic Skincare: The latest advancements in magnetic technology are empowering a new revolution in skincare. From skin tightening to moisture retention, they are defining the new anti-aging mantra in every way.
Hearing Contact Lenses: The continuous advancements in miniaturization, energy efficiency, and rapid adoption are driving the hearing contact lenses market to new heights. As the research efforts move towards improved user experience and efficacy, this niche is slated for expansion and diversification in the near future.
[newsletter_cta]